Page last updated: 2024-09-02

cobaltiprotoporphyrin and Cardiomyopathies

cobaltiprotoporphyrin has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abraham, NG; Chaudhry, M; Dodrill, MW; Drummond, CA; El-Hamdani, A; Haller, ST; Kennedy, DJ; Khawaja, AA; Liu, J; Martin, R; Maxwell, K; Robinette, TJ; Shah, PT; Shapiro, JI; Sodhi, K; Tian, J; Wang, X; Xie, Z; Yan, Y	1

Other Studies

1 other study(ies) available for cobaltiprotoporphyrin and Cardiomyopathies

Article	Year
Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy. Scientific reports, 2016, 10-04, Volume: 6 Topics: Animals; Cardiomyopathies; Disease Models, Animal; Enzyme Activators; Enzyme Inhibitors; Heme Oxygenase-1; Male; Mice, Inbred C57BL; Oxidants; Protoporphyrins; Reactive Oxygen Species; Sodium-Potassium-Exchanging ATPase; Treatment Outcome; Uremia	2016

Article

Year

Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy.

Scientific reports, 2016, 10-04, Volume: 6

Topics: Animals; Cardiomyopathies; Disease Models, Animal; Enzyme Activators; Enzyme Inhibitors; Heme Oxygenase-1; Male; Mice, Inbred C57BL; Oxidants; Protoporphyrins; Reactive Oxygen Species; Sodium-Potassium-Exchanging ATPase; Treatment Outcome; Uremia

2016